Literature DB >> 9421703

Vancomycin-resistant enterococci. Mechanism and clinical relevance.

G M Eliopoulos1.   

Abstract

Vancomycin-resistant enterococci have spread widely throughout the United States. Mechanisms of glycopeptide resistance are understood to a significant extent. These organisms are associated with considerable morbidity. Treatment options are limited, and control of their spread requires considerable effort and results in increased costs.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9421703     DOI： 10.1016/s0891-5520(05)70393-7

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN： 0891-5520            Impact factor:   5.982


  14 in total

1.  Comparative in vitro activities of ciprofloxacin, gemifloxacin, grepafloxacin, moxifloxacin, ofloxacin, sparfloxacin, trovafloxacin, and other antimicrobial agents against bloodstream isolates of gram-positive cocci.

Authors:  D Hardy; D Amsterdam; L A Mandell; C Rotstein
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

2.  In vitro activities of the glycylcycline GAR-936 against gram-positive bacteria.

Authors:  H W Boucher; C B Wennersten; G M Eliopoulos
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

Review 3.  Vancomycin-resistant enterococci.

Authors:  Y Cetinkaya; P Falk; C G Mayhall
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

4.  Pathogenic Mechanisms of Enterococcal Endocarditis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-08       Impact factor: 3.725

5.  Multidrug-resistant Pathogens: Mechanisms of Resistance and Epidemiology.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-10       Impact factor: 3.725

6.  Activities of a nitrofurazone-containing urinary catheter and a silver hydrogel catheter against multidrug-resistant bacteria characteristic of catheter-associated urinary tract infection.

Authors:  J R Johnson; P Delavari; M Azar
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

7.  Antibodies to a surface-exposed, N-terminal domain of aggregation substance are not protective in the rabbit model of Enterococcus faecalis infective endocarditis.

Authors:  J K McCormick; H Hirt; C M Waters; T J Tripp; G M Dunny; P M Schlievert
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

8.  Evaluation of the revised MicroScan dried overnight gram-positive identification panel to identify Enterococcus species.

Authors:  P C Iwen; M E Rupp; P C Schreckenberger; S H Hinrichs
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

9.  Is methicillin-resistant Staphylococcus aureus an emerging community pathogen? A review of the literature.

Authors:  M A Gardam
Journal:  Can J Infect Dis       Date:  2000-07

Review 10.  Dead bugs don't mutate: susceptibility issues in the emergence of bacterial resistance.

Authors:  Charles W Stratton
Journal:  Emerg Infect Dis       Date:  2003-01       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.